Mike Polark
Stock Analyst at Baird
(3.03)
# 1,034
Out of 4,667 analysts
75
Total ratings
100%
Success rate
16.95%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVRO Nevro | Maintains: Neutral | $5 → $6 | $4.36 | +37.61% | 10 | Nov 12, 2024 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $240 → $252 | $186.30 | +35.27% | 5 | Nov 5, 2024 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $100 → $79 | $73.90 | +6.90% | 7 | Nov 1, 2024 | |
| RMD ResMed | Downgrades: Underperform | $180 | $243.52 | -26.08% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $108.40 | - | 1 | Sep 10, 2024 | |
| SYK Stryker | Initiates: Outperform | $405 | $390.05 | +3.83% | 1 | Sep 10, 2024 | |
| LIVN LivaNova | Maintains: Neutral | $55 | $51.70 | +6.38% | 8 | Aug 28, 2024 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $70.38 | - | 3 | Jul 29, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $487 → $503 | $550.62 | -8.65% | 7 | Jul 19, 2024 | |
| PODD Insulet | Upgrades: Outperform | $200 | $262.00 | -23.66% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $117.26 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $190.58 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $74.46 | +62.50% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $30.74 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $12.41 | +101.45% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $169.12 | -2.44% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $91.51 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | n/a | $84.74 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $9.00 | +44.44% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $8.28 | +153.62% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $215.76 | +15.87% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $2.83 | +1,419.43% | 1 | Sep 2, 2020 |
Nevro
Nov 12, 2024
Maintains: Neutral
Price Target: $5 → $6
Current: $4.36
Upside: +37.61%
Inspire Medical Systems
Nov 5, 2024
Maintains: Outperform
Price Target: $240 → $252
Current: $186.30
Upside: +35.27%
iRhythm Technologies
Nov 1, 2024
Maintains: Outperform
Price Target: $100 → $79
Current: $73.90
Upside: +6.90%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $243.52
Upside: -26.08%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $108.40
Upside: -
Stryker
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $390.05
Upside: +3.83%
LivaNova
Aug 28, 2024
Maintains: Neutral
Price Target: $55
Current: $51.70
Upside: +6.38%
Edwards Lifesciences
Jul 29, 2024
Upgrades: Peer Perform
Price Target: n/a
Current: $70.38
Upside: -
Intuitive Surgical
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $550.62
Upside: -8.65%
Insulet
May 7, 2024
Upgrades: Outperform
Price Target: $200
Current: $262.00
Upside: -23.66%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $117.26
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $190.58
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $74.46
Upside: +62.50%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $30.74
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $12.41
Upside: +101.45%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $169.12
Upside: -2.44%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $91.51
Upside: -
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $84.74
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $9.00
Upside: +44.44%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $8.28
Upside: +153.62%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $215.76
Upside: +15.87%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $2.83
Upside: +1,419.43%